GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
OBJECTIVES: In this article, we describe how to include considerations about resource
utilization when making recommendations according to the Grading of Recommendations …
utilization when making recommendations according to the Grading of Recommendations …
Econometric issues in prospective economic evaluations alongside clinical trials: combining the nonparametric bootstrap with methods that address missing data
Prospective economic evaluations conducted alongside clinical trials have become an
increasingly popular approach in evaluating the cost-effectiveness of a public health …
increasingly popular approach in evaluating the cost-effectiveness of a public health …
Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002–11
Opioid use disorders are a significant public health problem, affecting two million people in
the United States. Treatment with buprenorphine, methadone, or both is predominantly …
the United States. Treatment with buprenorphine, methadone, or both is predominantly …
Supply of buprenorphine waivered physicians: the influence of state policies
Buprenorphine, an effective opioid use disorder treatment, can be prescribed only by
buprenorphine-waivered physicians. We calculated the number of buprenorphine-waivered …
buprenorphine-waivered physicians. We calculated the number of buprenorphine-waivered …
Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials
MGW Dijkgraaf, BP van der Zanden, CAJM de Borgie… - Bmj, 2005 - bmj.com
Objective To determine the cost utility of medical co-prescription of heroin compared with
methadone maintenance treatment for chronic, treatment resistant heroin addicts. Design …
methadone maintenance treatment for chronic, treatment resistant heroin addicts. Design …
Policies related to opioid agonist therapy for opioid use disorders: the evolution of state policies from 2004 to 2013
Background State Medicaid policies play an important role in Medicaid enrollees' access to
and use of opioid agonists, such as methadone and buprenorphine, in the treatment of …
and use of opioid agonists, such as methadone and buprenorphine, in the treatment of …
Drug treatment as HIV prevention: a research update
DS Metzger, GE Woody, CP O'Brien - JAIDS Journal of Acquired …, 2010 - journals.lww.com
Drug use continues to be a major factor fueling the global epidemic of HIV infection. This
article reviews the current literature on the ability of drug treatment programs to reduce HIV …
article reviews the current literature on the ability of drug treatment programs to reduce HIV …
ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individuals
Background and Objectives The most common treatment for opioid dependence is
substitution therapy with another opioid such as methadone. The methadone dosage is …
substitution therapy with another opioid such as methadone. The methadone dosage is …
Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder
Background Our objective was to examine the cost-effectiveness of flexible take-home
buprenorphine-naloxone (BNX) versus methadone alongside the OPTIMA trial in Canada …
buprenorphine-naloxone (BNX) versus methadone alongside the OPTIMA trial in Canada …
Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior—outcomes of a …
Aims Determine the extent to which buprenorphine injectors continue treatment with
buprenorphine-naloxone or methadone, and the impact of these treatments on substance …
buprenorphine-naloxone or methadone, and the impact of these treatments on substance …